{
  "ticker": "RCE",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959157",
  "id": "02959157",
  "pages": 9,
  "price_sensitive": true,
  "date": "20250617",
  "time": "1029",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250617/pdf/06ktkqn2mw0ykj.pdf",
  "summary": "### **Material Information Summary**  \n\n**Debt Facility Announcement:**  \n- **Structure**: Non-dilutive debt facility with Avenue Capital Group.  \n- **Total Facility Size**: Up to ~A$30m (US$20m), with **initial tranche of A$11.5m (US$7.5m)** committed.  \n- **Use of Proceeds**: Funding Phase 3 trials (Indonesia/Australia), manufacturing, regulatory submissions, and launch prep for R327G.  \n- **Pro-Forma Cash Position**: A$27.5m (including recent A$15.8m equity raise + debt drawdown).  \n- **Additional Liquidity**: FY25 R&D rebate of ~A$8.5m expected Nov-2025; total runway ~A$36m.  \n- **Key Terms**:  \n  - **Interest Rate**: 12.75% p.a., 24-month interest-only period.  \n  - **Warrants**: 8% coverage (initial US$1m/A$1.5m equity kicker), 5-year term, subject to ASX approval.  \n  - **Covenants**: No financial covenants; secured lien on assets (IP included).  \n\n**Capital Impact**: Strengthens near-term liquidity without immediate equity dilution; warrants introduce potential future dilution (~8% coverage).  \n\n**Omitted**: Operational pipeline details, management commentary, lender background.",
  "usage": {
    "prompt_tokens": 4038,
    "completion_tokens": 299,
    "total_tokens": 4337,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-17T01:28:56.715497"
}